您现在的位置是:知識 >>正文
【】
知識66人已围观
简介The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a ...
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
Featured Video For You
This biosensor allows doctors to monitor a patient's vitals from anywhere
TopicsHealth
Tags:
转载:欢迎各位朋友分享到网络,但转载请说明文章出处“夫榮妻貴網”。http://new.maomao321.com/news/76d54799376.html
相关文章
New Zealand designer's photo series celebrates the elegance of aging
知識Not only is age nothin’ but a number -- it can be a asset when it comes to style.。 That’ ...
【知識】
阅读更多Apple Music Replay reminds you which songs you binged the most in 2022
知識Apple Music Replay is back, and this time it's designed to be viewed on your phone. Once again, it's ...
【知識】
阅读更多Kevin Conroy, the iconic voice of Batman, has died at age 66
知識Kevin Conroy, the definitive voice of Batman for over 30 years, has died at the age of 66.The belove ...
【知識】
阅读更多
热门文章
- Michael Phelps says goodbye to the pool with Olympic gold
- FBI director shares TikTok data privacy concerns
- Donald Trump has an aide who follows him on the golf course to show him positive articles
- Wordle today: Here's the answer, hints for November 20
- Man stumbles upon his phone background in real life
- Folks in the U.S. can play Android games on Windows PCs now
最新文章
This chart shows just how high Simone Biles can jump
Elon Musk suspends Kanye West's Twitter account
The 10 best Disney+ dramas to stir your emotions
Uber Eats partners with Cartken for robot deliveries in Miami
How Hyperloop One went off the rails
2022 MAMA Awards voting disrupted because of 'internal changes within Twitter'